Although annexin A10 staining was positive in only 29% of patients with intrahepatic cholangiocarcinoma, its prognostic influence was strongest for this location relative to other primary tumor locations. This evidence concerns the gene ANXA10 and intrahepatic cholangiocarcinoma.